Introduction {#acn3381-sec-0001}
============

Although there is a general inverse association between cancer and Parkinson\'s disease (PD),[1](#acn3381-bib-0001){ref-type="ref"}, [2](#acn3381-bib-0002){ref-type="ref"} the one exception of melanoma has been well‐documented, not only in patients themselves but also in their relatives.[3](#acn3381-bib-0003){ref-type="ref"}, [4](#acn3381-bib-0004){ref-type="ref"} Little is known regarding mechanisms underlying the reciprocally increased risk of the two disparate diseases. However, efforts have been made in recent years to investigate potential genetic intersections and common pathological pathways.[2](#acn3381-bib-0002){ref-type="ref"}, [5](#acn3381-bib-0005){ref-type="ref"} Melanoma is strongly tied to red hair/fair skin, a phenotype of loss‐of‐function of the melanocortin‐1 receptor gene (*MC1R*), the key pigmentation gene.[6](#acn3381-bib-0006){ref-type="ref"} Our initial investigation based on more than 120,000 US men and women demonstrated that red hair color and red hair‐associated *MC1R* p.R151C polymorphism (rs1805007) were associated with higher risk of PD.[5](#acn3381-bib-0005){ref-type="ref"} *MC1R* variants have since garnered considerable interest and debate over their significance in the PD and melanoma association.[7](#acn3381-bib-0007){ref-type="ref"}, [8](#acn3381-bib-0008){ref-type="ref"}, [9](#acn3381-bib-0009){ref-type="ref"}, [10](#acn3381-bib-0010){ref-type="ref"}, [11](#acn3381-bib-0011){ref-type="ref"} In a case--control study based on 870 PD cases in Spain, another red hair‐associated *MC1R* variant p.R160W (rs1805008) was found to be associated with higher PD risk.[8](#acn3381-bib-0008){ref-type="ref"} However, other epidemiological studies on this topic did not support an *MC1R*‐PD link.[9](#acn3381-bib-0009){ref-type="ref"}, [10](#acn3381-bib-0010){ref-type="ref"}, [11](#acn3381-bib-0011){ref-type="ref"} In this report, we searched all literature indexed in PubMed and performed meta‐analyses of studies that examined the association between red hair color, *MC1R* p.R151C or p.R160W, two most studied *MC1R* loss‐of‐function polymorphisms, and PD risk.

Methods {#acn3381-sec-0002}
=======

Literature search and data extraction {#acn3381-sec-0003}
-------------------------------------

We searched all published literature in MEDLINE via PubMed up to July 2016 that reported PD associations with hair color, *MC1R* variants, and amino acid changes. For inclusion in *MC1R* variant analyses, all studies must have reported the specific variants or amino acid changes of interest, and the relative risks (RRs) or odds ratios (ORs). We extracted information on year of study, study type and population, cases and controls population size, country origin, focus of study, PD ascertainment method, variant of interest, lower and upper confidence intervals (CIs), minor allele frequency (MAF) in PD patients and controls, model or test type, and adjustment covariates.

Statistical analyses {#acn3381-sec-0004}
--------------------

We used Q statistic to examine heterogeneity among the studies and the significance level was set at 0.1. We used fixed‐effects models to calculate the summary ORs as no significant heterogeneity was identified (*P*‐heterogeneity ≥0.2 for all analyses). We did not adjust for multiple comparison because the current analyses were hypothesis‐driven. Publication bias was examined with the Begg and Egger tests.

Results {#acn3381-sec-0005}
=======

We identified six publications based on eight study cohorts in total from 2009 to 2016, all with study focus on hair color or *MC1R* p.R151C or p.R160W polymorphisms (Table [1](#acn3381-tbl-0001){ref-type="table-wrap"}).[5](#acn3381-bib-0005){ref-type="ref"}, [7](#acn3381-bib-0007){ref-type="ref"}, [8](#acn3381-bib-0008){ref-type="ref"}, [9](#acn3381-bib-0009){ref-type="ref"}, [10](#acn3381-bib-0010){ref-type="ref"}, [11](#acn3381-bib-0011){ref-type="ref"} PD cases were of US, French/French‐Canadian, UK, German, Greek, Dutch, and Spanish origins, overall representing white populations.[5](#acn3381-bib-0005){ref-type="ref"}, [7](#acn3381-bib-0007){ref-type="ref"}, [8](#acn3381-bib-0008){ref-type="ref"}, [9](#acn3381-bib-0009){ref-type="ref"}, [10](#acn3381-bib-0010){ref-type="ref"}, [11](#acn3381-bib-0011){ref-type="ref"} PD diagnosis was generally ascertained by a neurologist or clinician according to the United Kingdom Parkinson\'s Disease Society Brain Bank Criteria.

###### 

Characteristics of publications included in meta‐analysis of hair color, *MC1R* p.R151C, and p.R160W polymorphisms and risk for PD

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Publication (reference\#)                                 Study type                         Study/population                                                                             Study size                                             Exposures                      Effect estimate RR or OR (95% CI)   Adjustment
  --------------------------------------------------------- ---------------------------------- -------------------------------------------------------------------------------------------- ------------------------------------------------------ ------------------------------ ----------------------------------- -----------------------------------------------------------------------------------------------------
  Gao[5](#acn3381-bib-0005){ref-type="ref"}                 Cohort\                            HPFS\                                                                                        Cohort study: 132,302 participants and 539 PD cases\   Red versus black hair color\   RR = 1.93 (1.08, 3.43)\             smoking, ethnicity, BMI, nonsteroid antiinflammatory drug, alcohol intake, caffeine intake, lactose
                                                            nested case-- control              NHS                                                                                          Case--control study:\                                  p.R151C                        OR = 1.37 (0.99, 1.89)              
                                                                                                                                                                                            PD cases: 272 Controls: 1185                                                                                              

  Dong[7](#acn3381-bib-0007){ref-type="ref"}                Nested case-- control              PAGE within NIH‐AARP Diet and Health Cohort                                                  PD cases: 808 Controls: 1623                           Red versus black hair color\   OR = 1.36 (0.66, 2.79)\             age, sex, smoking status, and caffeine intake
                                                                                                                                                                                                                                                   p.R160W                        OR = 1.14 (0.89, 1.44)              

  Case--control                                             IPDGC                              PD cases: 5333 Controls: 12019                                                               p.R151C                                                OR = 1.06 (0.94, 1.09)                                             

  p.R160W                                                   OR = 0.98 (0.89, 1.07)                                                                                                                                                                                                                                    

  Tell‐Marti[8](#acn3381-bib-0008){ref-type="ref"}          Case--control                      Parkinson\'s Disease and Movement Disorders Unit of Hospital Clinic of Barcelona\            PD cases: 870 Controls: 736                            p.R151C                        OR = 1.25 (0.80, 1.95)              age, sex
                                                                                               Spanish Mediterranean Caucasians                                                                                                                                                                                       

  p.R160W                                                   OR = 2.10 (1.18, 3.73)                                                                                                                                                                                                                                    

  Lubbe[9](#acn3381-bib-0009){ref-type="ref"}               Cohort                             "An additional large cohort collected through IPDGC"[9](#acn3381-bib-0009){ref-type="ref"}   PD cases: 5944\                                        p.R160W                        OR = 1.01 (0.90, 1.13)              sex, population stratification
                                                                                                                                                                                            Controls: 4642                                                                                                            

  Gan‐Or[10](#acn3381-bib-0010){ref-type="ref"}             Case--control                      Columbia University Medical Center, New York                                                 PD cases: 539 Controls: 265                            p.R151C                        OR = 0.77 (0.48, 1.23)              age, sex

  p.R160W                                                   OR = 0.92 (0.53, 1.57)                                                                                                                                                                                                                                    

  Case--control                                             Montreal Neurological Institute\   PD cases: 551 Controls: 956                                                                  p.R151C                                                OR = 0.92 (0.57, 1.47)                                             
                                                            European ancestry                                                                                                                                                                                                                                         

  p.R160W                                                   OR = 1.13 (0.68, 1.90)                                                                                                                                                                                                                                    

  Lorenzo‐Betancor[11](#acn3381-bib-0011){ref-type="ref"}   Case--control                      Mayo Clinic\                                                                                 PD cases: 889 Controls: 940                            p.R151C                        OR = 1.27 (*P* = 0.068)             
                                                                                               Non‐Hispanic Caucasian                                                                                                                                                                                                 

  p.R160W                                                   OR = 1.06 (*P* = 0.62)                                                                                                                                                                                                                                    
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

RR, the relative risks; OR, odds ratios; CI, confidence intervals; HPFS, the health professionals follow‐up study; NHS, the nurses' health study; PD, Parkinson\'s disease; BMI, body mass index; PAGE, Parkinson\'s genes and environment; AARP, the American Association of Retired Persons; IPDGC, International Parkinson\'s Disease Genomics Consortium.
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Red hair was associated with significantly higher risk of PD, relative to black hair (pooled OR = 1.68; 95% CI: 1.07, 2.64; *P* = 0.02; PD case number = 1347[5](#acn3381-bib-0005){ref-type="ref"}, [7](#acn3381-bib-0007){ref-type="ref"}\] (Fig. [1](#acn3381-fig-0001){ref-type="fig"}A). When we further examined two *MC1R* red hair color alleles, we found that p.R151C variant was associated with marginally increased risk of PD (pooled OR = 1.101; 95% CI: 1.002, 1.210; *P* = 0.046; PD case number = 8454[5](#acn3381-bib-0005){ref-type="ref"}, [7](#acn3381-bib-0007){ref-type="ref"}, [8](#acn3381-bib-0008){ref-type="ref"}, [9](#acn3381-bib-0009){ref-type="ref"}, [10](#acn3381-bib-0010){ref-type="ref"}\] (Fig. [1](#acn3381-fig-0001){ref-type="fig"}B). However, we did not find significant association between p.R160W and PD risk (pooled OR = 1.019; 95% CI: 0.956, 1.807; *P* = 0.57; PD case number = 14,934)[7](#acn3381-bib-0007){ref-type="ref"}, [8](#acn3381-bib-0008){ref-type="ref"}, [9](#acn3381-bib-0009){ref-type="ref"}, [10](#acn3381-bib-0010){ref-type="ref"}, [11](#acn3381-bib-0011){ref-type="ref"} (Fig. [1](#acn3381-fig-0001){ref-type="fig"}C). There was no strong evidence of publication bias based on the Begg and Egger tests (*P* \> 0.05 for all).

![Pooled relative risks and their 95% confidence intervals (95% CIs) for Parkinson\'s disease (PD) according to red hair color status (A; 1347 PD cases), *MC1R* p.R151C (rs1805007) (B; 8454 PD cases), and p.R160W (rs1805008) (C; 14934 PD cases) polymorphisms. HPFS = the health professionals follow‐up study; NHS = the nurses' health study; PAGE = Parkinson\'s genes and environment; IPDGC = International Parkinson\'s Disease Genomics Consortium.](ACN3-4-212-g001){#acn3381-fig-0001}

Discussion {#acn3381-sec-0006}
==========

In this meta‐analysis of six publications, totaling eight study cohorts,[5](#acn3381-bib-0005){ref-type="ref"}, [7](#acn3381-bib-0007){ref-type="ref"}, [8](#acn3381-bib-0008){ref-type="ref"}, [9](#acn3381-bib-0009){ref-type="ref"}, [10](#acn3381-bib-0010){ref-type="ref"}, [11](#acn3381-bib-0011){ref-type="ref"} we found that red hair color was significantly associated with higher risk for PD. Red hair‐associated *MC1R* variant p.R151C had a significant association with PD risk. Another red hair color variant, p.R160W, was not associated with PD risk.

The associations of red hair color and *MC1R* p.R151C with PD risk are consistent with our initial report.[5](#acn3381-bib-0005){ref-type="ref"} Skin/hair color is determined by relative production of brown--black eumelanin and yellow--red pheomelanin. Binding to its ligand *α*‐melanocyte‐stimulating hormone, the G protein‐coupled MC1R induces synthesis of eumelanin through cAMP cascade.[6](#acn3381-bib-0006){ref-type="ref"}, [12](#acn3381-bib-0012){ref-type="ref"} Loss‐of‐function *MC1R* variants including p.R151C facilitate pheomelanin formation and are associated with red hair/fair skin and increased risk of melanoma.[6](#acn3381-bib-0006){ref-type="ref"}, [12](#acn3381-bib-0012){ref-type="ref"}, [13](#acn3381-bib-0013){ref-type="ref"} MC1R is also involved in the regulation of other cellular functions independent of pigmentation.[12](#acn3381-bib-0012){ref-type="ref"} Evidence supports a critical role of pheomelanin as a prooxidant in MC1R melanomagenesis,[6](#acn3381-bib-0006){ref-type="ref"} and involvement of red hair pigmentation in PD is supported by our original report[5](#acn3381-bib-0005){ref-type="ref"} and the present meta‐analysis. Other studies have also implicated a potential role of general pigmentation in PD. For example, primary skin cultures from individuals with red hair color showed deregulation of genes involved in neurodegenerative diseases such as PD.[14](#acn3381-bib-0014){ref-type="ref"} A clinical study reported a correlation between light pigmentation phenotype and increased echogenicity of the substantia nigra.[15](#acn3381-bib-0015){ref-type="ref"} Furthermore, a GWA study identified melanogenesis as significant pathways for PD.[16](#acn3381-bib-0016){ref-type="ref"} However, it is not clear whether skin/hair pigmentation accounts all or in part for *MC1R* p.R151C‐PD association.

Interestingly, despite limited knowledge about its biosynthetic pathway and its exact role in dopaminergic neuron degeneration, neuromelanin, the third melanin in humans in fact has a pheomelanin core and a eumelanin surface.[17](#acn3381-bib-0017){ref-type="ref"} This finding has led to a hypothesis that thinning eumelanin surface and exposing pheomelanin core may be responsible for the selective vulnerability of pigmented dopaminergic neurons in PD.[18](#acn3381-bib-0018){ref-type="ref"} Although early evidence supports expression of MC1R in brain,[19](#acn3381-bib-0019){ref-type="ref"} and MC1R has been proposed to be neuroprotective,[8](#acn3381-bib-0008){ref-type="ref"} it remains to be determined whether MC1R signaling plays any role in the synthesis and functions of neuromelanin and how neuromelanin is related to peripheral pigmentation, that is, skin/hair color.

*MC1R* p.R160W, another red hair‐associated polymorphism that was associated with higher PD risk in one study with a Spanish population,[8](#acn3381-bib-0008){ref-type="ref"} did not show a significant positive association in our meta‐analysis. One of the difficulties in ascertaining the association stems from the relatively low MAF and penetrance of *MC1R* in both PD and non‐PD patients[5](#acn3381-bib-0005){ref-type="ref"}, [7](#acn3381-bib-0007){ref-type="ref"}, [8](#acn3381-bib-0008){ref-type="ref"}, [9](#acn3381-bib-0009){ref-type="ref"}, [10](#acn3381-bib-0010){ref-type="ref"}, [11](#acn3381-bib-0011){ref-type="ref"} compared to other PD predisposing genes such as those of the family of *PARK* genes, though the frequency of *MC1R* mutations is comparable to those of melanoma cases.[6](#acn3381-bib-0006){ref-type="ref"}, [12](#acn3381-bib-0012){ref-type="ref"} Furthermore, the frequency of minor alleles differs between populations,[20](#acn3381-bib-0020){ref-type="ref"} and possible differential biological mechanisms and environmental interactions contributing to the mixed evidence for the association with PD should be clarified.

Although our original findings[5](#acn3381-bib-0005){ref-type="ref"} are generally supported by this meta‐analysis, larger, prospective cohorts with different ethnic backgrounds are needed to verify the associations between hair color, p.R151C, and possibly other *MC1R* red hair variants and PD risk. In addition, laboratory studies would provide critical insight into the mechanistic roles of *MC1R* and pigmentation in dopaminergic neuron degeneration in PD.
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